Peter Scammells

Projects

Projects per year 2001 2003 2005 2007 2008 2009 2016 2019 2022 2028

• 8 Active
• 41 Finished

Projects per year

Search results

• Finished

  New Syntheses of Pharmaceutical Opiates - Part 2

  Scammells, P. (Primary Chief Investigator (PCI))

  River Stone Biotech Australia Pty Ltd

  14/12/22 → 13/03/24

  Project: Research

• Newcastle University/Monash Academic Track (NUMAcT) scheme

  Mann, D. A. (Primary Chief Investigator (PCI)), Porter, C. (Chief Investigator (CI)) & Scammells, P. (Chief Investigator (CI))

  1/08/19 → 31/05/25

  Project: Other

• Chemical-Biology Approaches to Pathway Selective Adenosine Receptor Ligands

  Scammells, P. (Primary Chief Investigator (PCI)) & Christopoulos, A. (Chief Investigator (CI))

  1/07/19 → 4/07/23

  Project: Research

• Discovering novel allosteric probes of muscarinic acetylcholine receptors

  Valant, C. (Primary Chief Investigator (PCI)), Scammells, P. (Chief Investigator (CI)) & Christopoulos, A. (Chief Investigator (CI))

  3/06/19 → 31/12/22

  Project: Research

• New aminobenzimidazole antimalarial agents with a novel mechanism of action

  Creek, D. (Primary Chief Investigator (PCI)), Scammells, P. (Chief Investigator (CI)), Ralph, S. A. (Chief Investigator (CI)), Norton, R. (Chief Investigator (CI)) & Devine, S. (Chief Investigator (CI))

  1/01/19 → 31/12/21

  Project: Research

• The Development of APN Inhibitors as Potential Anti-Cancer Agents

  Lee, J. (Primary Chief Investigator (PCI)) & Scammells, P. (Supervisor)

  1/06/17 → 30/04/19

  Project: Research

• Allosteric and Bitopic Ligands Acting at G Protein-Coupled Receptors

  Scammells, P. (Primary Chief Investigator (PCI)) & Christopoulos, A. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University

  1/01/16 → 30/06/19

  Project: Research

• Distributed facility for fragment based drug discovery

  Scanlon, M. (Primary Chief Investigator (PCI)), Dixon, N. (Chief Investigator (CI)), Gooley, P. R. (Chief Investigator (CI)), Hughes, R. A. (Chief Investigator (CI)), Kwan, A. (Chief Investigator (CI)), Lewis, P. J. (Chief Investigator (CI)), Mackay, J. (Chief Investigator (CI)), Matthews, J. (Chief Investigator (CI)), Norton, R. (Chief Investigator (CI)), Oakley, A. J. (Chief Investigator (CI)) & Scammells, P. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University, University of Sydney, University of Wollongong, University of Newcastle, University of Melbourne

  1/01/16 → 27/09/16

  Project: Research

• Anti-Malarial Agents Targeting Apical Membrane Antigen 1

  Norton, R. (Primary Chief Investigator (PCI)), McGowan, S. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)) & Scanlon, M. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/16 → 31/12/18

  Project: Research

• DsbA inhibitors: from hits to leads

  Martin, J. L. (Primary Chief Investigator (PCI)), Scanlon, M. (Chief Investigator (CI)), Heras, B. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)) & Torsika, M. (Chief Investigator (CI))

  1/01/16 → 31/12/18

  Project: Research

• Understanding mechanisms of allostery and biased agonism at the adenosine A1 receptor

  Christopoulos, A. (Primary Chief Investigator (PCI)), May, L. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)) & Scott, D. J. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/15 → 31/12/17

  Project: Research

• Adenosine Receptor Biased Agonism to Treat Ischaemic Heart Disease

  May, L. (Primary Chief Investigator (PCI)), Scammells, P. (Chief Investigator (CI)), Wang, B. (Chief Investigator (CI)) & White, P. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/15 → 31/12/17

  Project: Research

• Targeting the Plasmodium falciparum Metalloaminopeptidases for Development of New Antimalarial Agents

  McGowan, S. (Primary Chief Investigator (PCI)) & Scammells, P. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/14 → 31/12/16

  Project: Research

• New Methodology for the Manufacture of Opioid Pharmaceuticals and the Discovery of Novel Opiate Receptor Ligands

  Scammells, P. (Primary Chief Investigator (PCI)), Graham, B. (Chief Investigator (CI)) & Campbell, S. (Partner Investigator (PI))

  ARC - Australian Research Council, GlaxoSmithKline (GSK) Australia, Monash University

  30/06/12 → 30/06/15

  Project: Research

• A New Class of Anti-Malarial Agents Targetting Apical Membrane Antigen

  Norton, R. (Primary Chief Investigator (PCI)), McGowan, S. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)) & Scanlon, M. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/12 → 31/12/14

  Project: Research

• Understanding Allosteric Modulation and Functional Selectivity at G Protein-Coupled Receptors

  Scammells, P. (Primary Chief Investigator (PCI)) & Christopoulos, A. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University

  4/01/11 → 31/12/14

  Project: Research

• The Synthesis and Pharmacological Evaluation of Novel Bivalent Dopamine D2 and Adenosine A2A Ligands for the Treatment of Parkinson s Disease

  Capuano, B. (Primary Chief Investigator (PCI)), Jorg, M. (Chief Investigator (CI)) & Scammells, P. (Chief Investigator (CI))

  ARC - Australian Research Council, GlaxoSmithKline (GSK) Singapore

  1/07/10 → 31/12/13

  Project: Research

• Applications of the Polonovski Reaction in the Synthesis of Bioactive Opiates

  Scammells, P. (Primary Chief Investigator (PCI)) & Capuano, B. (Chief Investigator (CI))

  ARC - Australian Research Council, GlaxoSmithKline (GSK) Australia

  21/12/09 → 31/12/12

  Project: Research

• High throughput analysis and screening facility

  Sexton, P. (Primary Chief Investigator (PCI)), Beddoe, T. (Chief Investigator (CI)), Charman, W. (Chief Investigator (CI)), Christopoulos, A. (Chief Investigator (CI)), Drummond, G. (Chief Investigator (CI)), Hertzog, P. (Chief Investigator (CI)), Mackay, C. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)) & Whisstock, J. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/12/09 → 30/11/10

  Project: Research

• Development of Novel Anti-Inflammatory Agents

  Krum, H. (Primary Chief Investigator (PCI)), Scammells, P. (Chief Investigator (CI)) & Wang, B. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/12/08 → 31/08/11

  Project: Research

• Focal Adhesion Kinase (FAK)

  Scammells, P. (Primary Chief Investigator (PCI)) & Pouton, C. (Chief Investigator (CI))

  1/07/08 → 31/12/12

  Project: Research

• CRC Cancer Therapeutics - Equipment

  Scammells, P. (Primary Chief Investigator (PCI))

  1/07/08 → 30/06/10

  Project: Research

• Allosteric Modulators as Novel Probes of G-Protein Coupled Receptor Function

  Scammells, P. (Primary Chief Investigator (PCI)), Christopoulos, A. (Chief Investigator (CI)) & Flynn, B. (Partner Investigator (PI))

  ARC - Australian Research Council

  2/01/08 → 31/12/11

  Project: Research

• X-ray Molecular Structure Elucidation Facillity (MSEF)

  El-Kabbani, O. (Primary Chief Investigator (PCI)), Abrahams, B. (Chief Investigator (CI)), Boskovic, C. (Chief Investigator (CI)), Cheng, H.-C. (Chief Investigator (CI)), Dakternieks, D. (Chief Investigator (CI)), Donnelly, P. (Chief Investigator (CI)), Duthie, A. (Chief Investigator (CI)), Holmes, A. B. (Chief Investigator (CI)), Hutton, C. A. (Chief Investigator (CI)), Jazayeri, J. (Chief Investigator (CI)), Kolev, S. (Chief Investigator (CI)), O'Hair, R. A. J. (Chief Investigator (CI)), Prankerd, R. (Chief Investigator (CI)), Rizzacasa, M. (Chief Investigator (CI)), Robson, R. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)), Schiesser, C. (Chief Investigator (CI)), Simpson, J. (Chief Investigator (CI)), Thompson, P. (Chief Investigator (CI)), Wedd, A. (Chief Investigator (CI)), White, J. (Chief Investigator (CI)), Wille, U. (Chief Investigator (CI)), Williams, S. J. (Chief Investigator (CI)) & Young, C. (Chief Investigator (CI))

  ARC - Australian Research Council, Monash University

  1/01/07 → 31/12/07

  Project: Research

• Finnigan LCQ Deca XP Max Ultra-Sensitive 3D Ion Tap L/MS(n) System

  Scammells, P. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/07 → 31/12/07

  Project: Research

• Refrigerated Incubator

  El-Kabbani, O. (Primary Chief Investigator (PCI)), Prankerd, R. (Chief Investigator (CI)) & Scammells, P. (Chief Investigator (CI))

  Collier Charitable Fund

  1/01/07 → 31/12/07

  Project: Research

• Design, Synthesis and Evaluation of Biodegradable Ionic Liquids

  Scammells, P. (Primary Chief Investigator (PCI))

  26/10/06 → 25/10/09

  Project: Research

• Synthesis of Novel Dual Acting, Selenium Containing Antioxidants

  Scammells, P. (Primary Chief Investigator (PCI)) & Schiesser, C. (Chief Investigator (CI))

  ARC - Australian Research Council

  1/01/06 → 31/12/08

  Project: Research

• Development of a diversity-oriented synthesis platform

  Scammells, P. (Primary Chief Investigator (PCI)) & Bui, C. (Partner Investigator (PI))

  ARC - Australian Research Council, Bionomics Ltd

  6/12/05 → 31/12/08

  Project: Research

• The development of novel task specific and biodegradable ionic liquids

  Scammells, P. (Primary Chief Investigator (PCI)) & Singer, R. (Chief Investigator (CI))

  ARC - Australian Research Council

  20/07/05 → 31/12/08

  Project: Research

• ARC Centre of Excellence - Centre for Free Radical Chemistry and Biotechnology

  Scammells, P. (Primary Chief Investigator (PCI)), Angus, J. (Chief Investigator (CI)), Bottle, S. (Chief Investigator (CI)), Coote, M. L. (Chief Investigator (CI)), Davies, M. J. (Chief Investigator (CI)), Easton, C. J. (Chief Investigator (CI)), Hearn, M. (Chief Investigator (CI)), Jackson, R. (Chief Investigator (CI)), O'Hair, R. A. J. (Chief Investigator (CI)), Radom, L. (Chief Investigator (CI)), Schiesser, C. (Chief Investigator (CI)), Sherburn, M. S. (Chief Investigator (CI)), Wille, U. (Chief Investigator (CI)), Barker, P. (Partner Investigator (PI)), Jarrott, B. (Partner Investigator (PI)), Rizzardo, E. (Partner Investigator (PI)), Rogers, P. A. W. (Partner Investigator (PI)) & Such, C. H. (Partner Investigator (PI))

  ARC - Australian Research Council, Monash University

  1/07/05 → 30/06/10

  Project: Research

• Discovery and development of dihydropteroate synthase (DHPS) inhibitors

  Swarbrick, J. (Primary Chief Investigator (PCI)), Macreadie, I. G. (Chief Investigator (CI)) & Scammells, P. (Chief Investigator (CI))

  Monash University

  1/04/05 → 30/03/06

  Project: Research

• Allosteric Enhancers: Leads for the Therapy of Cardiovascular Disease

  Scammells, P. (Primary Chief Investigator (PCI)) & Flynn, B. (Chief Investigator (CI))

  ARC - Australian Research Council

  1/02/05 → 30/06/08

  Project: Research

• Synthesis of novel selenium containing antioxidants and related therapeutic agents

  Scammells, P. (Primary Chief Investigator (PCI))

  Department of Jobs, Skills, Industry and Regions (DJSIR) (Victoria)

  2/09/04 → 31/12/04

  Project: Research

• Small Molecule NMR Facility of Accelerated Drug Discovery

  Scanlon, M. (Primary Chief Investigator (PCI)), Marriott, P. J. (Chief Investigator (CI)), Scammells, P. (Chief Investigator (CI)), Schiesser, C. (Chief Investigator (CI)), Separovic, F. (Chief Investigator (CI)) & Urban, S. (Chief Investigator (CI))

  University of Melbourne, Monash University, RMIT University, ARC - Australian Research Council

  1/01/04 → 31/12/04

  Project: Research

• Synthesis of Novel Selenium-Containing Antioxidants and Related Therapeutic Agents

  Scammells, P. (Primary Chief Investigator (PCI)) & Schiesser, C. (Chief Investigator (CI))

  1/10/03 → 30/09/06

  Project: Research

• Synthesis of Compounds CBL 316/330

  Scammells, P. (Primary Chief Investigator (PCI)) & Flynn, B. (Chief Investigator (CI))

  28/04/03 → 27/04/04

  Project: Research

• Synthesis of compound CBL 78

  Scammells, P. (Primary Chief Investigator (PCI))

  28/02/03 → 27/08/03

  Project: Research

• Enhanced drug delivery using nanoparticulate dendrimer vectors

  Porter, C. (Primary Chief Investigator (PCI)), Scammells, P. (Chief Investigator (CI)) & Krippner, G. (Partner Investigator (PI))

  ARC - Australian Research Council, Starpharma Pty Ltd

  1/01/03 → 30/06/06

  Project: Research

• Design and synthesis of novel anti-arrhythmic agents based on adenosine

  Scammells, P. (Primary Chief Investigator (PCI)) & Laws, M. (Chief Investigator (CI))

  Monash University

  1/01/02 → 31/12/03

  Project: Research

• Improved Synthesis of Commercially-Important Opiates

  Scammells, P. (Primary Chief Investigator (PCI))

  1/12/01 → 31/05/04

  Project: Research